1 / 17

ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC

Clinical Correlation Between Effective Anticoagulants & Risk of Stroke: Are We Using Evidence-Based Strategies. ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC. Southern Medical Journal 2004;97: 924-931. Trina La PharmD. Candidate Oct 20 th, 2011.

sveta
Download Presentation

ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinical Correlation Between Effective Anticoagulants & Risk of Stroke: Are We Using Evidence-Based Strategies ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Southern Medical Journal 2004;97: 924-931 Trina La PharmD. Candidate Oct 20th, 2011

  2. Introduction • Atrial fibrillation (AF) can predispose patients to blood clots that can cause stroke • If untreated, one in three people with nonvalvular AF will suffer a stroke • The importance & efficacy of anticoagulation therapy in preventing a stroke is a common knowledge & has become the standard of care

  3. Introduction • Warfarin was reported to be substantially more efficacious than aspirin • Anticoagulant prophylaxis is effective as INR of 2 to 3, and is associated with a lower risk of bleeding • However, despite extensive evidence & recommendations for its use, anticoagulant prophylaxis is underused in the management of AF

  4. Study’s Objective • Primary endpoint: To define correlation between effective anticoagulant prophylaxis and risk of thromboembolic stroke • Secondary endpoint: To observe & investigate the role of other factors, such as practice patterns in different settings

  5. Study Design • Patients with a diagnosis of AF requiring anticoagulation therapy & who were admitted between years 1997 & 2000 to community-based teaching hospital in Southeast Georgia were identified through a retrospective chart review • The sample consisted of 297 patients • 91 patients who suffered a stroke at any point during the study period • 206 patients who did not suffer a stroke by the end of year 2000

  6. Study design • Patients demographics, clinical diagnoses, findings & treating physicians were extracted from admission records • History of AF, duration of the disease, treatment modalities, indicators for anticoagulation therapy, & risk factors for comorbid diseases were obtained from hospital charts

  7. Study design • Two study groups • Warfarin: 124 patients • No Warfarin: 166 patients • No record of anticoagulation therapy: 7 patients • INR • Between 2.0 & 3.0 as therapeutic • Prescribing physician specialties • Neurologists • Cardiologists • General internists • Others

  8. Inclusion & Exclusion Inclusion Exclusion • A diagnosis of AF requiring anticoagulation therapy • Hypercoagulable state • Hemorrhagic stroke • Carotid stenosis • Peripheral vascular disease • Dilated cardiomyopathy

  9. Nature of the variables collected Variables collected Data Analysis • Age • INR • Gender • Race • Co-morbidities • Managing Physician Specialty • Normal probability plots & the Shapiro-Wilks test to assess the normality assumption • Chi-square test of independence to compare patients prescribed/not prescribed warfarin for each indicator variables • The risk of stroke associated with anticoagulation tx was assessed using 2x2 contingency table & stratified Mantel-Haenszel analysis

  10. Results

  11. Results • Higher warfarin dosages • Larger values in INR (r=+0.395) • Fewer strokes (r=-0.372) • Prescribed by cardiologists (0.289) • Greater occurrences of strokes are present in those patients under the care of neurologist (r=+0.394) • Average dosage of warfarin prescribed • Cardiologists: 2.94 mg • Neurologists: 1.76 mg

  12. Odds of Warfarin Prescription • Patients who were more likely to be prescribed warfarin when • History of AF & stroke (P=0.013) • Care management by a cardiologists (P=0.035) • Elderly patients were more likely to have additional comorbidities that influenced the prescription of warfarin • Neurologists (P=0.308) & internists(P=0.77) have similar patterns of prescribing warfarin when compared with cardiologists

  13. Odds of Stroke • Patients who are not prescribed warfarin have significantly higher risk of suffering a stroke • Patients with diagnosis of CHF in addition to AF were 6.8 times less likely to suffer a stroke when compared with AF patients without CHF • NNT: 50

  14. Author’s comment • Treatment of AF & anticoagulant prophylaxis are complex & time consuming clinical undertakings that requires long-term commitments • This study’s result with regard to the risk of stroke in patients with AF are consistent & in line with previously published studies • The elderly patients and the presence of co-morbid diseases play a significant role in the decision making process

  15. Limitations & Conclusion • Limitations • Many patients’ records revealed the presence of internist in addition to other specialists • There were some overlaps between the primary providers in ordering warfarin dosages • Conclusions • Despite extensive evidence supporting anticoagulation therapy, both physicians & patients are less inclined to more aggressive stroke prevention measures • Cost, fear of bleeding complications, drug interactions, & time are the factors influencing decision making • educational opportunities & an aggressive public awareness might be needed

  16. Comments • I think this is a very important study because it showed the correlation between effective anticoagulant on stroke prevention, and it raised the awareness of not fully use evidence-based strategies per physicians • However, the study did not document some essential information • History of compliance with warfarin • When patients started taking warfarin • How the physician adjust warfarin dosing • Record of all medications, including AF medications due to potential drug interaction • History of adverse drug events and complications

  17. Level of evidence

More Related